Method for preventing restenosis following reconfiguration of body vessels
US5116864A · kind A · utility
164Cited by
19References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1991 |
| Grant date | May 26, 1992 |
| Priority date | — |
| Expiry date | Apr 9, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N5/062
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Restenosis following vascular recanalization is prevented by administering a photoactivatable psoralen and, in conjunction with recanalization, delivering ultraviolet radiation to the region of said recanalization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.